| A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B (NCT03426618) | Bristol-Myers Squibb | 2018-01-12 |
| Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi) (NCT05002907) | Centre Hospitalier de Cayenne | 2018-01-01 |
| Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan (NCT03341195) | Aga Khan University | 2018-01-01 |
| Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar (NCT03579576) | Right to Care | 2017-12-20 |
| Entecavir to TAF Switch (NCT03489239) | Thomas Jefferson University | 2017-11-16 |
| Hepatitis B Vaccine for Non-responders (NCT03415672) | Maastricht University Medical Center | 2017-10-11 |
| A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants (NCT03285620) | Alios Biopharma Inc. | 2017-09-07 |
| Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg (NCT03396458) | Hasselt University | 2017-09-01 |
| Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria (NCT04264312) | Wu Jiang | 2017-07-28 |
| A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults (NCT03208101) | LG Chem | 2017-07-03 |
| Immunologic Response of Hepatitis B Vaccine (NCT03219203) | Chiang Mai University | 2017-07-01 |
| Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD (NCT03973502) | National Taiwan University Hospital | 2017-06-12 |
| Hepatitis B Virus Prevalence and Risk Factors in Belgium (NCT03425513) | Hasselt University | 2017-05-12 |
| Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France (NCT02959684) | University Paris 7 - Denis Diderot | 2017-04-14 |
| Pilot Study of HIV and Hepatitis B and C Screening in Surgery (NCT03088995) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2017-04-01 |
| To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy. (NCT03123653) | Institute of Liver and Biliary Sciences, India | 2017-03-17 |
| The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC (NCT03084250) | Shanghai Nanhui Nanhua Hospital | 2017-03-10 |
| Immunity to Hepatitis B Vaccine (NCT03083158) | University of British Columbia | 2017-03-06 |
| Characterisation of Human B Cell Maturation in Response to Vaccination (NCT03535779) | Imperial College London | 2017-03-06 |
| Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection (NCT02981602) | GlaxoSmithKline | 2017-02-24 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects (NCT03020745) | GlaxoSmithKline | 2017-02-14 |
| Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers (NCT03032536) | Alios Biopharma Inc. | 2017-01-31 |
| Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community (NCT04947475) | Yale University | 2017-01-01 |
| TAF Switch Study in Hepatitis B Monoinfection (NCT02957994) | Asian Pacific Liver Center at Coalition of Inclusive Medicine | 2016-12-22 |
| Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy (NCT02791386) | Bristol-Myers Squibb | 2016-11-22 |
| ID HBV Vaccination With Imiquimod in OBI (NCT03307902) | The University of Hong Kong | 2016-10-01 |
| French HIV-HBV Cohort (NCT02889094) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2016-10-01 |
| Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery (NCT02853929) | GlaxoSmithKline | 2016-09-19 |
| A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia (NCT02858440) | GlaxoSmithKline | 2016-09-13 |
| Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome (NCT03027258) | University of Nevada, Las Vegas | 2016-09-01 |
| A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy (NCT02798952) | GlaxoSmithKline | 2016-08-23 |
| A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada (NCT02985450) | University of Calgary | 2016-08-01 |
| DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants (NCT02817451) | Sanofi Pasteur, a Sanofi Company | 2016-07-14 |
| A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT02826018) | Alnylam Pharmaceuticals | 2016-06-24 |
| The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients (NCT03546530) | The First Hospital of Jilin University | 2016-06-01 |
| Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma (NCT02779465) | Third Affiliated Hospital, Sun Yat-Sen University | 2016-06-01 |
| Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies? (NCT02799316) | Sherief Abd-Elsalam | 2016-06-01 |
| A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB) (NCT02797522) | Arrowhead Pharmaceuticals | 2016-06-01 |
| Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy (NCT03181113) | Xiamen Amoytop Biotech Co., Ltd. | 2016-05-18 |
| Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study (NCT02766933) | Mayo Clinic | 2016-05-01 |
| A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV (NCT02751996) | F-star Therapeutics, Inc. | 2016-05-01 |
| Dynamic Liver Tests in Liver Disease (NCT02782247) | Queen Mary University of London | 2016-05-01 |
| Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) (NCT02759354) | MCM Vaccines B.V. | 2016-04-26 |
| Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection (NCT02738008) | Arrowhead Pharmaceuticals | 2016-03-01 |
| Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID (NCT02186977) | Novosanis NV | 2016-03-01 |
| Chronic Hepatitis B and C Recall Northern Holland (NCT02687061) | Stichting MDL Holland-Noord | 2016-02-01 |
| Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine. (NCT02697474) | Sanofi Pasteur, a Sanofi Company | 2016-02-01 |
| Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda (NCT04177485) | Centers for Disease Control and Prevention | 2016-02-01 |
| The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening (NCT04240678) | University of California, Davis | 2016-01-01 |
| Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients (NCT02849132) | Beijing Friendship Hospital | 2016-01-01 |
| First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects (NCT02647281) | GlaxoSmithKline | 2015-12-17 |
| Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan (NCT02402699) | Bristol-Myers Squibb | 2015-12-15 |
| Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) (NCT02577029) | Arrowhead Pharmaceuticals | 2015-12-01 |
| Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides (NCT02644538) | The Second Affiliated Hospital of Chongqing Medical University | 2015-12-01 |
| Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age (NCT02610348) | Sanofi Pasteur, a Sanofi Company | 2015-11-01 |
| A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection (NCT02604212) | Arrowhead Pharmaceuticals | 2015-11-01 |
| A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™ (NCT04179786) | VBI Vaccines Inc. | 2015-11-01 |
| A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) (NCT02584543) | Xiamen Innovax Biotech Co., Ltd | 2015-10-01 |
| A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection (NCT02604199) | Arrowhead Pharmaceuticals | 2015-09-01 |
| Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively (NCT02605538) | Karolinska University Hospital | 2015-09-01 |
| A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses (NCT02434848) | Sheffield Teaching Hospitals NHS Foundation Trust | 2015-07-23 |
| Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection (NCT02479880) | Gilead Sciences | 2015-07-03 |
| Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) (NCT02749864) | Instituto de Investigación Marqués de Valdecilla | 2015-07-01 |
| Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) (NCT02135666) | GlaxoSmithKline | 2015-05-01 |
| Tenofovir to Prevent HBV Reactivation (NCT02186574) | University Health Network, Toronto | 2015-05-01 |
| Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . (NCT02003703) | Universidad de Valparaiso | 2015-05-01 |
| Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates (NCT02764671) | Shenzhen Kangtai Biological Products Co., LTD | 2015-05-01 |
| Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth (NCT02428491) | Sanofi Pasteur, a Sanofi Company | 2015-04-20 |
| Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection (NCT02511743) | Peking University First Hospital | 2015-04-01 |
| Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation (NCT02417207) | Third Affiliated Hospital, Sun Yat-Sen University | 2015-04-01 |
| Hepatitis B Birth Dose for Newborns (NCT04870021) | Quaid-e-Azam University | 2015-03-15 |
| To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B (NCT02982837) | King Abdullah International Medical Research Center | 2015-03-01 |
| Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts (NCT02732054) | Chiang Mai University | 2015-03-01 |
| Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks (NCT02257645) | LG Life Sciences | 2015-03-01 |
| Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects (NCT02431312) | Inovio Pharmaceuticals | 2015-01-12 |
| Hepatitis B Vaccination in HIV-infected Adults (NCT02713620) | Chiang Mai University | 2015-01-01 |
| Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa (NCT02344498) | Oslo University Hospital | 2015-01-01 |
| Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients (NCT03149874) | Benha University | 2014-12-01 |
| Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B (NCT02288208) | TetraLogic Pharmaceuticals | 2014-11-01 |
| Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania (NCT04325542) | Medical Mission Institute, Germany | 2014-10-01 |
| This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age (NCT02324218) | GlaxoSmithKline | 2014-10-01 |
| Follow-up of HBsAg Inactive Carriers Study (NCT02247752) | Centre Hospitalier Régional d'Orléans | 2014-09-16 |
| A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV (NCT02421666) | Temple University | 2014-09-01 |
| Hepatitis B Booster Study in Adolescence (NCT02169674) | University of British Columbia | 2014-09-01 |
| Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study (NCT02548325) | Corporacion Parc Tauli | 2014-06-01 |
| Clinical Performance Evaluation of DxN HBV Assay (NCT03123159) | Beckman Coulter, Inc. | 2014-05-27 |
| A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines (NCT02032160) | University of Surrey | 2014-05-01 |
| Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine (NCT02445703) | Sinovac Biotech Co., Ltd | 2014-05-01 |
| Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B® (NCT04209400) | VBI Vaccines Inc. | 2014-04-18 |
| Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants (NCT02096263) | GlaxoSmithKline | 2014-04-16 |
| Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity (NCT02148562) | Universitaire Ziekenhuizen KU Leuven | 2014-04-01 |
| The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults (NCT02057263) | Massachusetts General Hospital | 2014-04-01 |
| HBV-HIV Coinfection Research Network (NCT01924455) | Virginia Commonwealth University | 2014-04-01 |
| A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults (NCT02203357) | Peking University | 2014-03-01 |
| DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants (NCT02094833) | Sanofi Pasteur, a Sanofi Company | 2014-03-01 |
| Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers (NCT02055365) | Rockefeller University | 2014-02-18 |
| This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa (NCT02052661) | GlaxoSmithKline | 2014-02-18 |
| Patient-Centered Care and Asian Americans (NCT02139722) | University of California, San Francisco | 2014-01-02 |
| Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA (NCT02012998) | Sanofi Pasteur, a Sanofi Company | 2014-01-01 |
| Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis (NCT01998620) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2013-11-01 |